Novo Reaches Winning Post With Gamechanger Once-Weekly Insulin

The Danish drugmaker is cementing its leadership in diabetes with an imminent approval in Europe for Awiqli which reduces the number of basal insulin injections for patients from seven to just one per week.

insulin hormone vials-single use syringe_1200x675
• Source: Shutterstock

It is just over 100 years since Novo Nordisk A/S started producing insulin and the Danish company is now on the verge of getting approval for Awiqli, the world's first once-weekly insulin.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Alimentary/Metabolic

More from Therapy Areas